ArticleThe Lancet. Global health2024

Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.

W Yvonne Joko-Fru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.